{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T17:27:14Z","timestamp":1771608434294,"version":"3.50.1"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Alma Mater Studiorum - University of Bologna"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/j.jpba.2020.113584","type":"journal-article","created":{"date-parts":[[2020,8,30]],"date-time":"2020-08-30T18:52:32Z","timestamp":1598813552000},"page":"113584","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Ampicillin sodium: Isolation, identification and synthesis of the last unknown impurity after 60 years of clinical use"],"prefix":"10.1016","volume":"191","author":[{"given":"Alessandra","family":"Tolomelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Viola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Bassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Ferrazzano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Martelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexia","family":"Mattellone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Cabri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2020.113584_bib0005","unstructured":"F. P. Doyle, J. H. Nayler, H. Smith, Improvements in or relating to penicillin derivatives, Beecham Research Laboratories Limited (UK) (1958) Patent GB873049."},{"key":"10.1016\/j.jpba.2020.113584_bib0010","unstructured":"F. P. Doyle, J. H. Nayler, H. Smith, H. Penicillins, Beecham Research Laboratories Limited (UK), (1960) Patent GB902703."},{"key":"10.1016\/j.jpba.2020.113584_bib0015","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/j.1476-5381.1962.tb01416.x","article-title":"Pharmacology and chemotherapy of ampicillin -A new broad\u2010spectrum penicillin","volume":"18","author":"Acred","year":"1962","journal-title":"Brit. J. Pharmacol. Chemother."},{"key":"10.1016\/j.jpba.2020.113584_bib0020","article-title":"Cover stories: a rising drug industry the pharmaceutical golden era: 1930 \u2013 60","volume":"25","author":"Daemmerich","year":"2005","journal-title":"Chem. Eng. News"},{"key":"10.1016\/j.jpba.2020.113584_bib0025","first-page":"103","article-title":"History of antimicrobial agents and resistant bacteria","volume":"52","author":"Saga","year":"2009","journal-title":"Japan Med. Assoc. J."},{"key":"10.1016\/j.jpba.2020.113584_bib0030","doi-asserted-by":"crossref","first-page":"577","DOI":"10.2165\/00003495-198733060-00003","article-title":"Sulbactam\/ampicillin. A Review of Its Antibacterial Activity, Pharmacokinetic Properties, and Therapeutic Use","volume":"33","author":"Campoli-Richards","year":"1987","journal-title":"Drugs"},{"key":"10.1016\/j.jpba.2020.113584_bib0035","first-page":"ME01","article-title":"Ampicillin: rise, fall and resurgence","volume":"8","author":"Kaushik","year":"2014","journal-title":"J. Clin. Diagn. Res."},{"key":"10.1016\/j.jpba.2020.113584_bib0040","series-title":"Healthcare Market Data","author":"IQUVIA","year":"2020"},{"key":"10.1016\/j.jpba.2020.113584_bib0045","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/anie.196404391","article-title":"Synthesis of 6-[(D-\u03b1-amino-\u03b1-phenylacetyl)amino]-penicillanic acid using \u03b2-dicarbonyl compounds as amino protecting groups","volume":"3","author":"Dane","year":"1964","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.jpba.2020.113584_bib0050","unstructured":"EP10.0, 2019, edqm.eu\/en\/european-pharmacopoeia-ph-eur-10th-edition."},{"key":"10.1016\/j.jpba.2020.113584_bib0055","series-title":"ICH Quality Guidelines","year":"2020"},{"key":"10.1016\/j.jpba.2020.113584_bib0060","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0731-7085(87)80011-0","article-title":"Application of 1H nuclear magnetic resonance spectroscopy to the analysis of \u03b2-lactam antibiotics and their common degradation products","volume":"5","author":"Branch","year":"1987","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2020.113584_bib0065","series-title":"Biorad Free Database 2020","author":"Spectrabase","year":"2020"},{"key":"10.1016\/j.jpba.2020.113584_bib0070","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/rcm.6834","article-title":"Electrospray ionization collision-induced dissociation tandem mass spectrometry of amoxicillin and ampicillin and their degradation products","volume":"28","author":"Franski","year":"2014","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.jpba.2020.113584_bib0075","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.jpba.2009.02.027","article-title":"Determination of relative response factors for chromatographic investigations using NMR spectrometry J. Pharm","volume":"49","author":"Webster","year":"2009","journal-title":"Biomed. Anal."},{"key":"10.1016\/j.jpba.2020.113584_bib0080","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jpba.2014.04.016","article-title":"Pharmaceutical Impurities and Degradation Products: Uses and Applications of NMR Techniques","volume":"101","author":"Maggio","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2020.113584_bib0085","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1021\/js960428p","article-title":"Isolation and structure elucidation of the major degradation products of cefaclor in the solid state","volume":"86","author":"Dorman","year":"1997","journal-title":"J.Pharm.Sci."},{"key":"10.1016\/j.jpba.2020.113584_bib0090","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1021\/acsomega.6b00235","article-title":"Metal-free oxidative coupling of Benzylamines to Imines under an oxygen atmosphere promoted using salicylic acid derivatives as organocatalysts","volume":"1","author":"Dong","year":"2016","journal-title":"ACS Omega"},{"key":"10.1016\/j.jpba.2020.113584_bib0095","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1021\/ol4010118","article-title":"Iron-catalyzed direct synthesis of Imines from amines or alcohols and amines via aerobic oxidative reactions under air","volume":"15","author":"Zhang","year":"2013","journal-title":"Org. Lett."},{"key":"10.1016\/j.jpba.2020.113584_bib0100","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1021\/acssuschemeng.8b03966","article-title":"Ferrocenium promoted oxidation of benzyl amines to imines using water as the solvent and air as the oxidant","volume":"7","author":"Deb","year":"2019","journal-title":"ACS Sustainable Chem. Eng."},{"key":"10.1016\/j.jpba.2020.113584_bib0105","series-title":"Much Adoe About Nothing Play Included in the First Folio Collection","author":"Shakespeare","year":"1623"}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708520314709?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708520314709?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T09:05:17Z","timestamp":1760000717000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708520314709"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11]]},"references-count":21,"alternative-id":["S0731708520314709"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2020.113584","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ampicillin sodium: Isolation, identification and synthesis of the last unknown impurity after 60 years of clinical use","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2020.113584","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113584"}}